📰 Combangio Inc News
Combangio Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Combangio Inc. Real-time updates on events, politics, business and more.
April 28, 2023
Shares of Kala Pharmaceuticals, Inc. (KALA) are rising more than 6% Friday morning at $16.43..
April 28, 2023
Shares of Kala Pharmaceuticals, Inc. (KALA) are rising more than 6% Friday morning at $16.43..
March 3, 2023
-- Enrolled first patient in CHASE Phase 2b clinical trial evaluating KPI-012 for PCED; Top-line data targeted for 1Q 2024 -- -- Closed $31.0 million... | March 3, 2023
November 21, 2021
-- KPI-012 is a novel secretome with a multifactorial mechanism of action for development in PCED and other orphan ocular surface diseases driven by...